Magnus Bäck Selected Research

Leukotriene Receptors (Leukotriene Receptor)

4/2009	Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
6/2008	Inflammatory signaling through leukotriene receptors in atherosclerosis.
9/2007	Leukotriene receptors: crucial components in vascular inflammation.
1/2006	Leukotriene receptors in atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus Bäck Research Topics

Disease

46	Atherosclerosis 01/2022 - 07/2004
32	Inflammation (Inflammations) 12/2021 - 10/2005
20	Aortic Valve Stenosis (Aortic Stenosis) 10/2022 - 03/2011
15	Cardiovascular Diseases (Cardiovascular Disease) 02/2020 - 10/2006
10	Hyperplasia 11/2019 - 11/2005
9	Myocardial Infarction 10/2021 - 03/2010
8	Atherosclerotic Plaque (Atheroma) 10/2018 - 11/2005
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2017
6	Stroke (Strokes) 12/2019 - 10/2006
6	Thrombosis (Thrombus) 01/2019 - 05/2009
5	Obesity 01/2021 - 08/2009
5	Hypoxia (Hypoxemia) 01/2018 - 08/2009
5	Vascular System Injuries 01/2012 - 11/2005
4	Pathologic Constriction (Stenosis) 10/2020 - 04/2009
3	Aortic Valve Disease 01/2021 - 01/2017
3	Vascular Calcification 01/2021 - 01/2019
3	Disease Progression 01/2021 - 10/2018
3	Obstructive Sleep Apnea 01/2018 - 08/2009
3	Rupture 11/2014 - 02/2009
2	Hemorrhage 11/2022 - 01/2021
2	Infections 12/2020 - 01/2018
2	COVID-19 12/2020 - 01/2020
2	Chronic Renal Insufficiency 01/2020 - 01/2019
2	Insulin Resistance 12/2019 - 01/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019 - 11/2013
2	Abdominal Obesity 12/2019 - 01/2014
2	Rheumatoid Arthritis 01/2019 - 01/2018
2	Abdominal Aortic Aneurysm 12/2018 - 05/2009
2	Hypertension (High Blood Pressure) 01/2018 - 11/2013
2	Heart Failure 01/2017 - 08/2012
2	Neoplasms (Cancer) 11/2016 - 08/2014
2	Acute Coronary Syndrome 01/2013 - 10/2006
2	Vascular Remodeling 09/2012 - 03/2010
2	Ischemic Stroke 08/2012 - 03/2012
1	Heart Diseases (Heart Disease) 11/2022
1	Peritonitis 12/2021
1	Infarction (Infarctions) 01/2021

Drug/Important Bio-Agent (IBA)

23	LipidsIBA 01/2022 - 08/2007
22	LeukotrienesIBA 01/2019 - 10/2006
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2005
11	Leukotriene B4IBA 10/2018 - 07/2004
10	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 10/2014
8	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2018 - 04/2007
7	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2020 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2005
6	Apolipoproteins E (ApoE)IBA 01/2018 - 04/2007
5	ApolipoproteinsIBA 01/2022 - 08/2013
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 11/2017
5	Messenger RNA (mRNA)IBA 01/2019 - 08/2010
4	Biological ProductsIBA 12/2021 - 03/2010
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2014
4	EnzymesIBA 12/2020 - 05/2009
4	Arachidonic Acid (Vitamin F)IBA 01/2020 - 05/2007
4	ThromboxanesIBA 11/2013 - 08/2010
4	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2013 - 01/2009
4	Leukotriene Receptors (Leukotriene Receptor)IBA 04/2009 - 01/2006
3	nilotinib FDA Link 10/2022 - 01/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 01/2018
3	CalciumIBA 02/2020 - 12/2019
3	EicosanoidsIBA 01/2020 - 03/2013
3	Triglycerides (Triacylglycerol)IBA 12/2019 - 01/2018
3	montelukast (Singulair)FDA Link 01/2018 - 03/2012
3	cysteinyl-leukotrieneIBA 01/2018 - 08/2009
3	lipoxin A4IBA 11/2017 - 08/2014
3	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 03/2010
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2013 - 11/2009
2	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2016
2	Lipoprotein(a)IBA 01/2022 - 01/2021
2	resolvin D1IBA 12/2021 - 01/2017
2	Eicosapentaenoic AcidIBA 10/2021 - 11/2019
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2019
2	CytokinesIBA 12/2020 - 01/2020
2	Phenobarbital (Luminal)FDA Link 10/2020 - 05/2009
2	IronIBA 12/2019 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2014
2	CholesterolIBA 01/2019 - 01/2019
2	canakinumab FDA Link 01/2019 - 01/2018
2	LipoxinsIBA 12/2018 - 01/2018
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 12/2018 - 01/2015
2	oxidized low density lipoproteinIBA 10/2018 - 01/2018
2	C-Reactive ProteinIBA 01/2018 - 11/2013
2	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2018 - 10/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017 - 01/2015
2	Docosahexaenoic AcidsIBA 01/2017 - 10/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 05/2015 - 04/2015
2	Conditioned Culture MediaIBA 11/2013 - 05/2009
2	Leukotriene E4IBA 01/2013 - 08/2009
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2012 - 11/2009
2	Chemotactic FactorsIBA 05/2009 - 07/2004
1	Blood Glucose (Blood Sugar)IBA 11/2022
1	Discoidin Domain ReceptorsIBA 10/2022
1	resolvin D2IBA 01/2022
1	ZymosanIBA 12/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	N 30IBA 01/2021

Therapy/Procedure

8	Therapeutics 11/2022 - 11/2005
3	Transcatheter Aortic Valve Replacement 01/2022 - 05/2015
3	Secondary Prevention 01/2019 - 03/2012
2	Ligation 01/2018 - 01/2015
1	Carotid Endarterectomy 12/2021